BioPharma Dive8h
Moderna earnings beat forecasts, but analysts question whether sales spike will last
Sales of Moderna’s COVID-19 shot exceeded expectations, but the company’s launch of its new RSV vaccine has started slowly.
FiercePharma10h
Moderna disappoints in RSV debut, squares up with Pfizer in COVID-19 vaccine sales
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
Moderna shares surge after vaccine maker posts unexpected third-quarter profit
Moderna (NASDAQ:MRNA) has reported a surprise net income in the third quarter and announced changes at its leadership team, ...
Moderna’s stock pops after biotech ekes out profit and revenue beats by a wide margin
Moderna Inc.’s stock jumped 5% early Thursday, after the company’s third-quarter earnings showed an unexpected profit and ...
Investopedia on MSN7h
Moderna Stock Rises on Surprise Q3 Profit
Moderna reported better third-quarter results than expected Thursday morning, as the vaccine maker reported a surprise profit ...
The Boston Globe1d
Moderna sales get lift from early nod for newest COVID shot
He’s taking over a commercial assignment that was held by Stephane Bancel, who will remain chief executive officer. The ...
CNBC on MSN13h
Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold
Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last ...
Business Insider19h
Moderna promotes Jacqueline Miller to Chief Medical Officer, expands Hoge’s role
Dr. Loughlin will join the Executive Committee and report to Chief Executive Officer Stephane Bancel. Jacqueline Miller, M.D., has been promoted to Chief Medical Officer, and will lead Moderna’s ...